Business● Low22m ago · Nov 10, 2026, 2:03 PM
PMV Pharmaceuticals GAAP EPS of -$0.52 misses by $0.18
GlobeAlert Desk · curated from Seeking Alpha Tech · global
PMV Pharmaceuticals reported a Generally Accepted Accounting Principles (GAAP) Earnings Per Share (EPS) of -$0.52, which missed analyst estimates by $0.18. This indicates a financial performance that fell short of expectations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoUpstream Bio reports Q3 resultsSeeking Alpha TechBusiness20m agoGain Therapeutics GAAP EPS of -$0.07 beats by $0.05Seeking Alpha TechBusiness21m agoInflation remained elevated in October, CPI report showsCBS NewsBusiness22m agoOctober CPI: Gas tanks and hospital bills up, used cars and soda downSeeking Alpha Tech